Alan Baumeister, Professor

Office: 324 Audubon Hall
Department of Psychology
Louisiana State University
Baton Rouge, LA 70803
Office Phone: 225-578-8745
Email: [email protected]

Dr. Baumeister is not accepting new students at this time.

Research Interests

Dr. Baumeister's primary area of research is neurophilosophy. 

Education

• BS, University of Alabama, 1976
• MS, Peabody College, 1978
• PhD,Psychology, Peabody College, Vanderbilt University, 1981
• Postdoctoral Fellow, Neuropharmacology; Biological Sciences Research Center, University of North Carolina School of Medicine, January 1982 - May 1984
• Assistant Research Scientist; Department of Medical Pharmacology and Toxicology, College of Medicine, Texas A&M University, June 1984 - August 1985

Representative Publications

Baumeister, A.A. (2021) Is attention deficit hyperactivity disorder a risk syndrome for Parkinson's disease.  Harvard Review of Psychiatry 29: 142-158.

Pow, Joni Lee, Baumeister, Alan A., Cohen, Alex S. Garand, James C (2022). Deinstitutionalization and the Impact of Antipsychotics Versus Policy Change. Ethical Human Psychology and Psychiatry 29: DOI:10.1891/EHPP-2022-0001

Baumeister, A.A.. Could Clinical Use of Stimulant Medications Increase Risk for Parkinson’s Disease or Other Neurological Sequelae? A Review of the Evidence. J of Pharmacol & Clin Res. 2017, 3(4): 555618. DOI: 10.19080/JPCR.2017.02.555618.

Lee Pow J., Baumeister A.A., Hawkins, M.F., Cohen, A.S., Garand, J.: Deinstitutionalization of American public hospitals for the mentally ill before and after the introduction of antipsychotic medications. Harvard Review of Psychiatry, 2015, 23:176-187.

Baumeister, A.A., Hawkins, M.F., Lee Pow, J., Cohen A.S. Prevalence and Incidence of severe mental illness in the United States: A Historical Analysis, Harvard Review of Psychiatry, 2012, 20: 247-258.

Baumeister, A.A. The Chlorpromazine Enigma. The Journal of the History of the Neurosciences, 2013, 22, 14-29.

Baumeister, A.A., Henderson, K., LeePow, J., Advokat, C. The early history of the neuroscience of attention-deficity/hyperactivity disorder. Journal of the History of the Neurosciences, 2012, 21: 263-279.

Baumeister, A.A. The search for an endogenous schizogen: The strange case of taraxein, Journal of the history of the Neurosciences, 2011, 20: 106-122.

Baumeister, A.A., Hawkins, López-Muñoz, F. Toward standardized usage of the word serendipity in the histriography of psychopharmacology. Journal of the History of the Neurosciences, 2010, 19, 253-270.

Baumeister, A.A. Serendipity and the cerebral localization of pleasure.Journal of the History of the Neurosciences, 2006, 15, 92-98.

Baumeister, A.A. & Hawkins, M.F. Continuity and discontinuity in the historical development of modern of psychopharmacology, Journal of the History of the Neurosciences, 2005, 14, 199-209.

Baumeister, A.A., & Hawkins M.F. The serotonin hypothesis of schizophrenia. A historical case study on the heuristic value of theory in clinical neuroscience, Journal of the History of the Neurosciences, 2004, 13, 289-303.

Baumeister, A.A., Hawkins, M.F., & Uzelac, S.M. The myth of reserpine-induced depression. Role in the historic development of the monoamine hypothesis. Journal of the History of the Neurosciences, 2003, 12, 207-220.

Baumeister, A.A., & Francis, J. Historical development of the dopamine hypothesis of schizophrenia, Journal of the History of the Neurosciences, 2002, 11, 265-277.

Baumeister, A.A., & Hawkins, M.F. Incoherence of neuroimaging studies of attention deficit/hyperactivity disorder. Clinical Neuropharmacology, 2001, 24, 2-10.

Baumeister, A.A. The Tulane electrical brain stimulation program. A historical case study in medical ethics. Journal of the History of the Neurosciences, 2000, 9, 263-278.